{"schema":"sb.node.v1","id":"sb:e/2a28be127f5e47d52762d001","kind":"entity","label":{"text":"sun pharma","locale":"en"},"identity":{"anchor":"label:en:sun pharma","strength":"label"},"asOf":{"knowledgeCutoff":"2026-11-14T23:28:43.035217+00:00","releaseId":"sb-5b40e4d7d30d","snapshot":"deploy 91e869b821be7c94b2f02275beb4b22dad0cccf7"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":63,"separatePublishers":19,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"partial","share":0.19,"named":12,"of":63,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn only from rows whose own title or URL names the subject (the entity graph's subject gate)","blind":["only 19% of the 63 documents measured name the subject in their own text; the rest mention it in passing, so standing.evidence.supporting overstates coverage about it"]}},"admission":{"state":"canonical","kind":"legacy","kindBasis":"promoted-before-receipts","reason":"entity graph provenance 'curated'; promoted from the corpus by the machine rule before promotion receipts were written (2026-10-02); no receipt exists and none is invented","policy":"promotion (admitted before receipts existed; no receipt)","admittedOn":"2026-09-30"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-05-15","to":"2026-11-10","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","share":0.016,"blind":["2% of mentions say something specific about it; the rest only name it"]}},"dimensions":{"domains":["india_south_asia"],"activeDays":32,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":7,"byKind":{"observation":7},"withheld":{"state":"withheld","count":3,"reason":"3 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/a663ac6893622bb62d2f26a6","kind":"observation","label":"Business News India · 2026-11-08 · Muhurat Trading 2026: Sensex, Nifty open higher in special session; Tata Steel, Sun Pharma shares among top gainers","url":"https://www.businesstoday.in/markets/stocks/story/muhurat-trading-2026-sensex-nifty-open-higher-in-special-session-tata-steel-sun-pharma-shares-among-top-gainers-566371-2026-11-08?utm_source=rssfeed","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/f56eac9662088679f8716ed4","kind":"observation","label":"Hindustan Times Business · 2026-11-08 · Diwali muhurat trading LIVE updates: Tata Steel, Sun Pharma lead early gains; Infosys, M&M slip","url":"https://www.hindustantimes.com/business/diwali-muhurat-trading-live-updates-sensex-nifty-to-open-for-special-session-at-2-20-pm-investors-eye-blue-chip-stocks-101794125048058.html","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/041f20617ba6df50d6f595ba","kind":"observation","label":"Economic Times · 2026-10-30 · Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges","url":"https://economictimes.indiatimes.com/markets/stocks/earnings/sun-pharma-q2-results-profit-falls-36-yoy-to-rs-1989-crore-on-exceptional-charges/articleshow/135352681.cms","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/d2f4b93cb4e9eb3765973465","kind":"observation","label":"STAT News · 2026-10-30 · STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more","url":"https://www.statnews.com/pharmalot/2026/10/30/astrazeneca-cost-cutting-sun-pharma-facility-problems/?utm_campaign=rss","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/a36eb79176cc14b08fd81a71","kind":"observation","label":"The Hindu · 2026-10-30 · India orders Sun Pharma to halt eye-care drug production at plant after quality lapses","url":"https://www.thehindu.com/business/india-orders-sun-pharma-to-halt-eye-care-drug-production-at-plant-after-quality-lapses/article71646516.ece","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/e263a08ad270534c6a13bc5b","kind":"observation","label":"Economic Times · 2026-10-23 · Sun Pharma raises Rs 7,816 crore, misses bond target","url":"https://economictimes.indiatimes.com/markets/bonds/sun-pharma-raises-rs-7816-crore-misses-bond-target/articleshow/135130994.cms","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/fcdf9a664ad36bd2c4e6d27e","kind":"observation","label":"FDA Drug News · 2026-05-15 · Sun Pharmaceutical Industries, Inc. (Sun Pharma) Initiates Voluntary U.S. Nationwide Recall of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL Due To Potential Pr…","url":"http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sun-pharmaceutical-industries-inc-sun-pharma-initiates-voluntary-us-nationwide-recall-doxorubicin","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}}],"cursor":null,"order":"newest first; we keep the 7 newest receipts for this entity whose own title or URL (the entity graph's subject gate) names it; each says which in match. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with india (36 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/fa96b33b731712af339c51ca"},{"kind":"relation","label":"co-mentioned with nifty (36 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/0fb386aed3a69cb70731aad5"},{"kind":"relation","label":"co-mentioned with oil (34 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/9a33e71bd9609d9a1490e4d9"},{"kind":"relation","label":"co-mentioned with sensex (31 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/f524d8ac687b92b14b3218d0"},{"kind":"relation","label":"co-mentioned with brent crude (27 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a1d3fcab9562a69b511f04d1"},{"kind":"relation","label":"co-mentioned with asian (26 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/d07cd51b23ffe20442d8560a"},{"kind":"relation","label":"co-mentioned with crude oil prices (24 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/e0163d178adc72346c709700"},{"kind":"relation","label":"co-mentioned with bse sensex (22 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ce30dee92f43ef90ffbaec48"},{"kind":"relation","label":"co-mentioned with nse nifty (22 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/90892c3d9dca5d744397a69e"},{"kind":"relation","label":"co-mentioned with adani ports (20 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ef5bde428a52fbc4a98cfaf2"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/2a28be127f5e47d52762d001","mcp":"traverse {\"id\":\"sb:e/2a28be127f5e47d52762d001\"}","page":"/entity/sun-pharma/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/2a28be127f5e47d52762d001\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/2a28be127f5e47d52762d001\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"free-record","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/2a28be127f5e47d52762d001\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"free-record","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/2a28be127f5e47d52762d001\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"free-record","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history, which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"free-record","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"free-record","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"watch","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"watch","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"watch","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"watch","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"one-time-read","reason":"one-time Reads are not offered through this door; use ask"}]}